primary prophylaxis
Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5 fluorouracil
... as primary prophylaxis and the remaining 59 pa- tients were allocated to the control group in study ...as primary prophylaxis of adverse events and the advan- tage of pegfilgrastim use in DCF ...
6
Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia
... for primary prophylaxis of FN in chemo- therapy patients has the potential to reduce direct medical costs associated with FN by reducing rates of hospitaliza- tion, serious infections, and the use of ...
8
Effects of primary prophylaxis of neutropenia on outcomes, utilization and expenditures for elderly breast cancer patients receiving chemotherapy
... Also, dose reduction and dose delay to control neutropenia hinder the effective administration of a planned treatment regimen, diminish the efficacy of chemotherapy and radiation therapy, harm patient health outcomes and ...
218
Management of Plasmodium vivax risk and illness in travelers
... causal prophylaxis against ...for primary prophylaxis for travelers despite preventing both primary attacks of all the plasmodia and relapses of ...requires primary causal ...
6
Granulocyte colony stimulating factors for febrile neutropenia prophylaxis following chemotherapy : systematic review and meta analysis
... as primary prophylaxis (in every chemotherapy cycle from cycle 1) or as secondary prophylaxis (in all remain- ing cycles following a neutropenic event such as FN or prolonged severe ...
12
Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes
... universal prophylaxis in the initial 6–12 months is low, at less than 1 %, compared to the historically reported statistic from pre-prophylaxis era of 5 to 15% ...receive primary prophylaxis ...
7
Immunoblot Profile as Predictor of Toxoplasmic Encephalitis in Patients Infected with Human Immunodeficiency Virus
... Before the era of highly active antiretroviral therapy (HAART), toxoplasmic encephalitis (TE) was the second- most-common AIDS-related opportunistic infection after pneumocystosis, and the most common cause of central ...
6
Key words
... the primary prophylaxis was an antiplatelet drug ...improper primary prophylaxis in patients with AF with a high risk of ischemic stroke, the authors recommend a simple blood test to estimate ...
6
Granulocyte Colony-Stimulating Factor Use in a Large Iranian Hospital: Comparison with American Society of Clinical Oncology (ASCO) Clinical Practice Guideline
... of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic ...
7
Successful Parental Use of an Automated External Defibrillator for an Infant With Long-QT Syndrome
... Congenital long-QT syndrome with 2:1 atrioventricular block presenting in the perinatal period is rare, has a poor prognosis, and leads to high risk for lethal ventricular arrhythmic events. An implantable ...
6
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
... that primary prophylaxis with each of the three G-CSFs is effective in reducing the risk of FN following ...no primary G-CSF, [22-24] whereas at the time of a previous systematic review [18] only a ...
11
Rheumatic Fever Prevention in Industrializing Countries: Problems and Approaches
... If we compare the low cost of penicillin used in primary prophylaxis of RF with the consequences of this disease such as: the length of prophylaxis, the patients handicaps, the social co[r] ...
5
Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
... the first joint bleed and secondary when started after the age of 2 years and/or after more than 1 joint bleed. Primary prophylaxis is the gold standard treatment for children with severe hemophilia A. ...
7
Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people
... There are two broad approaches to preventing cryptococcal dis- ease. The first method (primary prophylaxis) consists of treating all those with a low CD4 count with prophylactic antifungals, while ...
49
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
... male. Primary prophylaxis with posaconazole was administered to 13 patients and systemic antifungal treatment under induction or consolidation chemotherapy to seven ...antifungal prophylaxis with ...
8
Risk of pneumocystosis after early discontinuation of prophylaxis among HIV infected patients receiving highly active antiretroviral therapy
... discontinued primary prophylaxis after CD4 counts increased to ^200 cells/μL, 1 case of pneumocystosis was diagnosed with an incidence rate of ...of primary pro- phylaxis, yielding an incidence rate ...
8
Duration and intensity of fluconazole for prophylaxis in preterm neonates: a meta analysis of randomized controlled trials
... that prophylaxis with fluconazole or nystatin may be beneficial over no prophylaxis in terms of the incidence of invasive fungal infections but that it is unlikely to produce a better outcome in terms of ...
7
ANTIBIOTIC PROPHYLAXIS
... Antibiotics have been employed by some physicians in an attempt to reduce the in- cidence of secondary bacterial infections among children who are suffering from a chronic noninfectious [r] ...
8
Treatment and chemoprevention of NSAID-associated gastrointestinal complications
... Combination treatment with a proton pump inhibi- tor and a selective COX-2 inhibitor has been suggested for optimal gastrointestinal protection in the highest risk patients, particularly those who have had complicated ...
10
A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
... Iran. Primary outcome was to assess the situation of VTE prophylaxis in pregnant and postpartum women and the secondary outcome was risk stratification in obstetrics patients and to evaluate the guideline ...
5